Publications by authors named "Simona Gervickaite"
Facial basal cell carcinoma (BCC) is the most common skin cancer, yet delays in diagnosis and treatment persist. These delays affect quality of life (QoL), advance disease progression, and increase healthcare burden. This study explores the relationship between symptom diversity, QoL, and care-seeking behaviors, focusing on the impact of symptoms on clinical outcomes and consultation timing.
View Article and Find Full Text PDFArticle Synopsis
- The study investigated the impact of facial basal cell carcinoma on quality of life (QoL), focusing on translating and validating the Lithuanian version of the Skin Cancer Index (SCI) for use in clinical settings.
- A longitudinal study with 100 patients revealed that surgical treatment significantly improves QoL, especially noticeable six months post-operation, while identifying factors like gender, treatment methods, and tumor locations that correlate with lower QoL.
- The Lithuanian SCI proved to be a valid tool for evaluating QoL in facial BCC patients, highlighting the importance of understanding various influences on QoL for effective patient care.
Article Synopsis
- Facial basal cell carcinoma (BCC) surgery can improve quality of life (QoL), but patients still experience lower QoL due to post-surgery scarring, highlighting the importance of understanding aesthetic satisfaction.
- The study validated the Lithuanian version of the Patient and Observer Scar Assessment Scale (POSAS) 2.0, which was used to analyze scar differences and their correlations with various factors like age, gender, and surgery type.
- Findings showed that the Lithuanian POSAS 2.0 is a reliable tool for measuring post-surgical scars and revealed that QoL is significantly affected by scar assessment, particularly among women, younger patients, and those with scars on the cheek after six months.